Sumitomo Dainippon Pharma Co., Ltd.

R&D Meeting

February 28, 2017

Font Size
  • S
  • M
  • L

R&D Meeting

Sumitomo Dainippon Pharma Co., Ltd.
Masayo Tada,
Representative Director, President and Chief Executive Officer

Hiroshi Noguchi,
Representative Director, Senior Executive Vice President

Antony Loebel,
Executive Officer Head of Global Clinical Development for Sumitomo Dainippon Pharma Group
Executive Vice President, Chief Medical Officer, Sunovion Pharmaceuticals Inc.

David J. Bearss,
Chief Executive Officer, Tolero Pharmaceuticals, Inc.
  • Forward-Looking Statements
  • System Requirements
  • Questionnaire